Enhanced GSK-3β expression in colon carcinoma samples was associated with resistance to 5-FU and in vitro inhibition of GSK-3β abolished cell viability via necroptosis and reduced xenograft growth in vivo [41]. The gene discussed is GSK3B; the disease is colon carcinoma.